Physician profile
Eric Rosier
NPI 1790770253
$1,384.50
in general payments reported to CMS, 2019-2025
9 companies · $386 in 2025
The $386 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.88 · 2020: $213 · 2021: $92.41 · 2022: $126 · 2023: $244 · 2024: $226 · 2025: $386.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $856.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $855.72 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals Lp | $345.69 | 2024-2025 | Fasenra, Andexxa |
| Janssen Pharmaceuticals, INC | $247.97 | 2021-2023 | Xarelto |
| Allergan, INC. | $241.34 | 2019-2020 | |
| E.R. Squibb & Sons, L.L.C. | $226.94 | 2019-2023 | Reblozyl |
| Xeris Pharmaceuticals, INC. | $124.59 | 2025 | Gvoke Hypopen |
| Abbvie INC. | $121.86 | 2024 | |
| Pfizer INC. | $45.00 | 2019 | |
| Viatris Specialty LLC | $19.58 | 2025 | Yupelri |
| Merck Sharp & Dohme LLC | $11.53 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Rosier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.